Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

IPA

Interpharm (IPA)

Interpharm Holdings, Inc.
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:IPA
DataHoraFonteTítuloCódigoCompanhia
29/04/200807:03Edgar (US Regulatory)Interpharm Holdings Inc - Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:IPAInterpharm Holdings, Inc.
25/04/200810:42Edgar (US Regulatory)Interpharm Holdings Inc - Current report filing (8-K)AMEX:IPAInterpharm Holdings, Inc.
22/04/200814:34Business WireInterpharm Announces Voluntary AMEX DelistingAMEX:IPAInterpharm Holdings, Inc.
16/04/200817:15Business WireInterpharm Receives Notice from American Stock ExchangeAMEX:IPAInterpharm Holdings, Inc.
03/03/200818:25Edgar (US Regulatory)Interpharm Holdings Inc - Statement of Changes in Beneficial Ownership (4)AMEX:IPAInterpharm Holdings, Inc.
03/03/200818:24Edgar (US Regulatory)Interpharm Holdings Inc - Statement of Beneficial Ownership (SC 13D)AMEX:IPAInterpharm Holdings, Inc.
15/02/200820:12Edgar (US Regulatory)Interpharm Holdings Inc - Quarterly Report (10-Q)AMEX:IPAInterpharm Holdings, Inc.
14/02/200815:22Edgar (US Regulatory)Interpharm Holdings Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:IPAInterpharm Holdings, Inc.
16/01/200818:53Edgar (US Regulatory)Interpharm Holdings Inc - Information Statement - All Other (definitive) (DEF 14C)AMEX:IPAInterpharm Holdings, Inc.
16/01/200809:03Edgar (US Regulatory)Interpharm Holdings Inc - Information Statements (revised) (PRER14C)AMEX:IPAInterpharm Holdings, Inc.
26/12/200709:12Edgar (US Regulatory)Interpharm Holdings Inc - Proxy Statement - Other Information (preliminary) (PRE 14C)AMEX:IPAInterpharm Holdings, Inc.
19/11/200719:51Edgar (US Regulatory)Interpharm Holdings Inc - Initial Statement of Beneficial Ownership (3)AMEX:IPAInterpharm Holdings, Inc.
15/11/200720:25Edgar (US Regulatory)Interpharm Holdings Inc - Annual Report (10-K)AMEX:IPAInterpharm Holdings, Inc.
15/10/200714:06Edgar (US Regulatory)Interpharm Holdings Inc - Amended Current report filing (8-K/A)AMEX:IPAInterpharm Holdings, Inc.
28/09/200717:39Edgar (US Regulatory)Interpharm Holdings Inc (Other) (NT 10-K)AMEX:IPAInterpharm Holdings, Inc.
16/05/200710:25Business WireInterpharm Announces Financial Results for the Three Month Period Ended March 31, 2007AMEX:IPAInterpharm Holdings, Inc.
15/11/200615:15Business WireInterpharm Announces Record Revenues and Profits for the Three Month Period Ended September 30, 2006AMEX:IPAInterpharm Holdings, Inc.
03/10/200616:09Business WireInterpharm Announces Record Revenues for the Fiscal Year Ended June 30, 2006AMEX:IPAInterpharm Holdings, Inc.
02/06/200609:30Business WireInterpharm Announces Closing of $10 Million Capital FinancingAMEX:IPAInterpharm Holdings, Inc.
19/05/200613:50Business WireInterpharm Announces $10 Million Capital FinancingAMEX:IPAInterpharm Holdings, Inc.
16/05/200609:00Business WireInterpharm Continues Record Revenue for the Fiscal 2006AMEX:IPAInterpharm Holdings, Inc.
15/02/200611:00Business WireInterpharm Announces 83% Increase in Revenue for the Fiscal Quarter Ended December 31, 2005 over the Prior YearAMEX:IPAInterpharm Holdings, Inc.
13/02/200620:16PR Newswire (US)Wells Fargo Business Credit Provides $41.5 Million Credit Facility to Interpharm, Inc.AMEX:IPAInterpharm Holdings, Inc.
22/11/200510:30Business WireInterpharm Announces Revenue and Earnings for the Fiscal Quarter Ended September 30, 2005AMEX:IPAInterpharm Holdings, Inc.
29/09/200508:30Business WireInterpharm Announces Revenue and Earnings for the Fiscal Year Ended June 30, 2005AMEX:IPAInterpharm Holdings, Inc.
21/09/200509:15Business WireInterpharm Launches Generic Equivalent of Bactrim(R) AntibioticAMEX:IPAInterpharm Holdings, Inc.
18/07/200509:04Business WireInterpharm Announces Introduction Of A Female Hormone Product With First Year Revenue Of $11.5 MillionAMEX:IPAInterpharm Holdings, Inc.
16/06/200410:01PR Newswire (US)Watson Pharmaceuticals Announces Launch of New Acute Pain Product in Collaboration With InterpharmAMEX:IPAInterpharm Holdings, Inc.
23/03/200410:19PR Newswire (US)Interpharm Announces FDA Approval of Hydrocodone Bitartrate and Ibuprofen 5/200 mg Tablets, a New Dosage Strength of the GenericAMEX:IPAInterpharm Holdings, Inc.
26/02/200410:25PR Newswire (US)Interpharm Clarifies Comparative Financial HistoryNYSE:IPA
 Apresentando as notícias mais relevantes sobre:AMEX:IPA